Corporate reporting of intellectual capital: Evidence from the Bangladeshi pharmaceutical sector

Asian Review of Accounting

Volumn 22, Issue 2, 2014, Pages 98-127

  Abhayawansa, Subhash ^a   Azim, Mohammad ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Bangladesh; Content analysis; Intellectual capital; Pharmaceutical sector

Indexed keywords

EID: 85006166472     PISSN: 13217348     EISSN: 17588863     Source Type: Journal    
DOI: 10.1108/ARA-10-2013-0067     Document Type: Article

References (92)

1. Abeysekera, I. (2008), Intellectual Capital Accounting: Practices in a Developing Country, Routledge, New York, NY.
2. Abeysekera, I. (2010), "The influence of board size on intellectual capital disclosure by Kenyan listed firms", Journal of Intellectual Capital, Vol. 11 No. 4, pp. 504-518.
3. Abeysekera, I. and Guthrie, J. (2005), "An empirical investigation of annual reporting trends of intellectual capital in Sri Lanka", Critical Perspectives on Accounting, Vol. 16 No. 3, pp. 151-163.
4. Abhayawansa, S. (2014), "A review of guidelines and frameworks on external reporting of intellectual capital", Journal of Intellectual Capital, Vol. 15 No. 1, pp. 100-141.
5. Abhayawansa, S.A. (2011), "A methodology for investigating intellectual capital information in analyst reports", Journal of Intellectual Capital, Vol. 12 No. 3, pp. 446-476.
6. Abhayawansa, S. and Guthrie, J. (2012), "Intellectual capital information and stock recommendations: impression management?", Journal of Intellectual Capital, Vol. 13 No. 3, pp. 398-415.
7. Abhayawansa, S. and Johnson, R. (2007), "Corporate governance reforms in developing countries: Accountability versus performance?", in Johnson, R. (Ed.), Readings in Auditing, John Wiley & Sons Australia, Milton, pp. 84-98.
8. ACI Limited (2006), Annual Report 2006 - Committed to Excellence, ACI Limited, Dhaka.
9. Ali, M.M., Khan, M.H.U.Z. and Fatima, J.K. (2008), "Intellectual capital reporting practices: Evidence from Bangladesh", Dhaka University Journal of Business Studies, Vol. 29 No. 1, pp. 23-45.
10. April, K.A., Bosma, P. and Deglon, D.A. (2003), "IC measurement and reporting: Establishing a practice in SA mining", Journal of Intellectual Capital, Vol. 4 No. 2, pp. 165-180.
11. Azim, M.I., Ahmed, S. and Islam, S. (2009), "Corporate social reporting practice: Evidence from listed companies in Bangladesh", Journal of Asia-Pacific Business, Vol. 10 No. 1, pp. 130-145.
12. Beattie, V., McInnes, B. and Fearnley, S. (2004), "A methodology for analysing and evaluating narratives in annual reports: A comprehensive descriptive profile and metrics for disclosure quality attributes", Accounting Forum, Vol. 28 No. 3, pp. 205-236.
13. Belal, A. (2001), "A study of corporate social disclosures in Bangladesh", Managerial Auditing Journal, Vol. 16 No. 5, pp. 274-289.
14. Belal, A.R. and Owen, D.L. (2007), "The views of corporate managers on the current state of, and future prospects for, social reporting in Bangladesh: An engagement-based study", Accounting, Auditing & Accountability Journal, Vol. 20 No. 3, pp. 472-494.
15. Berthelot, S., Cormier, D. and Magnan, M. (2003), "Environmental disclosure research: Review and synthesis", Journal of Accounting Literature, Vol. 22 No. 1, pp. 1-44.
16. Beximco Pharmaceuticals Limited (2006), Annual Report 2006 - We Are Moving Forward, Beximco Pharmaceuticals Limited, Dhaka.
17. Bollen, L., Vergauwen, P. and Schnieders, S. (2005), "Linking intellectual capital and intellectual property to company performance", Management Decision, Vol. 43 No. 9, pp. 1161-1185.
18. Bozzolan, S., Favotto, F. and Ricceri, F. (2003), "Italian annual intellectual capital disclosure: An empirical analysis", Journal of Intellectual Capital, Vol. 4 No. 4, pp. 543-558.
19. Campbell, D.J. (2000), "Legitimacy theory or managerial reality construction? Corporate social disclosure in Marks and Spencer Plc corporate reports, 1969-1997", Accounting Forum, Vol. 24 No. 1, pp. 80-100.
20. Chen, M.-C. (2004), "Intellectual capital and competitive advantages: The case of TTY Biopharm Company", Journal of Business Chemistry, Vol. 1 No. 1, pp. 14-20.
21. Cho, C.H., Roberts, R.W. and Patten, D.M. (2010), "The language of US corporate environmental disclosure", Accounting, Organizations and Society, Vol. 35 No. 4, pp. 431-443.
22. Chung, K.H. and Charoenwong, C. (1991), "Investment options, assets in place, and the risk of stocks", Financial Management, Vol. 20 No. 3, pp. 21-33.
23. Comyns, B., Figge, F., Hahn, T. and Barkemeyer, R. (2013), "Sustainability reporting: The role of 'Search', 'Experience' and 'Credence' information", Accounting Forum, Vol. 37 No. 3, pp. 231-243.
24. Cowan, S. and Gadenne, D. (2005), "Australian corporate environmental reporting: A comparative analysis of disclosure practices across voluntary and mandatory disclosure systems", Journal of Accounting & Organizational Change, Vol. 1 No. 2, pp. 165-179.
25. da Silva Monteiro, S.M. and Aibar-Guzman, B. (2009), "Determinants of environmental disclosure in the annual reports of large companies operating in Portugal", Corporate Social Responsibility and Environmental Management, Vol. 17 No. 4, pp. 185-204.
26. Davison, J. (2010), "[In]visible [in]tangibles: visual portraits of the business élite", Accounting, Organizations and Society, Vol. 35 No. 2, pp. 165-183.
27. Deegan, C. and Rankin, M. (1996), "Do Australian companies report environmental news objectively? An analysis of environmental disclosures by firms prosecuted successfully by the environmental protection authority", Accounting, Auditing and Accountability Journal, Vol. 9 No. 2, pp. 50-67.
28. Dong, S. and Burritt, R. (2010), "Cross-sectional benchmarking of social and environmental reporting practice in the Australian oil and gas industry", Sustainable Development, Vol. 18 No. 2, pp. 108-118.
29. Dowling, J. and Pfeffer, J. (1975), "Organizational legitimacy: social values and organizational behaviour", Pacific Sociological Review, Vol. 18 No. 1, pp. 122-136.
30. Dye, R.A. (1985), "Disclosure of nonproprietary information", Journal of Accounting Research, Vol. 23 No. 1, pp. 123-145.
31. Ensslin, S.R. and De Carvalho, F.N. (2007), "Voluntary disclosure of intellectual capital in the Brazilian context: An investigation informed by the international context", International Journal of Accounting, Auditing and Performance Evaluation, Vol. 4 No. 4, pp. 478-500.
32. European commission (2006), reporting intellectual capital to augment research, development and innovation in smes (RICARDIS): Encourage Corporate Measuring and Reporting on Research and Other Forms of Intellectual Capital, Directorate-General for Research, European Commission, Brussels.
33. Ferdous, A. (2011), "Working conditions in the Bangladesh readymade garments industry: is social compliance making a difference?", unpublished thesis, La Trobe University, Melbourne.
34. Flöstrand, P. (2006), "The sell side - observations on intellectual capital indicators", Journal of Intellectual Capital, Vol. 7 No. 4, pp. 457-473.
35. Gassmann, O., Reepmeyer, G. and Zedtwitz, M.v. (2008), Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry, Springer, Heidelberg.
36. GlaxoSmithKline Bangladesh Limited (2006), Annual Report 2006 - Fanning the Flames of Hope, GlaxoSmithKline (Bangladesh) Limited, Dhaka.
37. Goh, P.C. and Lim, K.P. (2004), "Disclosing intellectual capital in company annual reports: Evidence from Malaysia", Journal of Intellectual Capital, Vol. 5 No. 3, pp. 500-510.
38. Gray, R., Kouhy, R. and Lavers, S. (1995), "Corporate social and environmental reporting: A review of the literature and a longitudinal study of UK disclosure", Accounting, Auditing & Accountability Journal, Vol. 8 No. 2, pp. 47-77.
39. Guthrie, J. and Petty, R. (2000), "Intellectual capital: Australian annual reporting practices", Journal of Intellectual Capital, Vol. 1 No. 3, pp. 241-251.
40. Guthrie, J., Petty, R. and Ricceri, F. (2006), "The voluntary reporting of intellectual capital: comparing evidence from Hong Kong and Australia", Journal of Intellectual Capital, Vol. 7 No. 2, pp. 254-271.
41. Guthrie, J., Ricceri, F. and Dumay, J. (2012), "Reflections and projections: A decade of intellectual capital accounting research", The British Accounting Review, Vol. 44 No. 2, pp. 68-82.
42. Guthrie, J., Petty, R., Yongvanich, K. and Ricceri, F. (2004), "Using content analysis as a research method to inquire into intellectual capital reporting", Journal of Intellectual Capital, Vol. 5 No. 2, pp. 282-293.
43. Hans-Jü rgen, F. (2006), "In search of sustainability: process R&D in light of current pharmaceutical industry challenges", Drug Discovery Today, Vol. 11 Nos 21-22, pp. 966-974.
44. Haroon, J.U. (2012), "Local pharma market reaches $1.13 billion", available atwww.thefinancialexpress-bd.com/more.php?news-id=121262&date=2012-02-25(accessed 15 February 2013).
45. Healy, P.M. and Palepu, K.G. (2001), "Information asymmetry, corporate disclosure, and the capital markets: A review of the empirical disclosure literature", Journal of Accounting and Economics, Vol. 31 Nos 1-3, pp. 405-440.
46. Higgins, C. and Walker, R. (2012), "Ethos, logos, pathos: strategies of persuasion in social/environmental reports", Accounting Forum, Vol. 36 No. 3, pp. 194-208.
47. Highhouse, S., Brooks, M.E. and Gregarus, G. (2009), "An organizational impression management perspective on the formation of corporate reputations", Journal of Management, Vol. 35 No. 6, pp. 1481-1493.
48. Huang, H.-C., Lai, M.-C. and Lin, T.-H. (2011), "Aligning intangible assets to innovation in biopharmaceutical industry", Expert Systems With Applications, Vol. 38 No. 4, pp. 3827-3834.
49. Hussain, F. (2013), "Pharma mirror own research: pharmacists' satisfaction in professional life in Bangladesh", available at: Www.pharmamirror.com/pharmaceutical-Articles/ownresearch-pharmacists-satisfaction-in-professional-life-in-bangladesh (accessed 15 August 2013).
50. Ismail, T.H. (2011), "Intellectual capital reporting in knowledge economy of Egypt", International Journal of Critical Accounting, Vol. 3 Nos 2-3, pp. 293-317.
51. Joshi, M. and Ubha, D.S. (2009), "Intellectual capital disclosures: The search for a new paradigm in financial reporting by the knowledge sector of Indian economy", Electronic Journal of Knowledge Management, Vol. 7 No. 5, pp. 575-582.
52. Joshi, M., Ubha, D.S. and Sidhu, J. (2011), "Intellectual capital disclosures in India: A case study of information technology sector", Global Business Review, Vol. 12 No. 1, pp. 37-49.
53. Kamath, B. (2008a), "Intellectual capital disclosure in India: content analysis of 'TecK firms' ", Journal of Human Resource Costing & Accounting, Vol. 12 No. 3, pp. 213-224.
54. Kamath, G.B. (2008b), "Intellectual capital and corporate performance in Indian pharmaceutical industry", Journal of Intellectual Capital, Vol. 9 No. 4, pp. 684-704.
55. Khan, A.R. (2013a), "Prospects of Bangladesh economy", available at: Www.academia.edu/2325844/Prospects-of-Bangladesh-Economy (accessed 15 August 2013).
56. Khan, T.H. (2013b), "Middle class boom: image of new Bangladesh", available at: Www.dailysun.com/details-yes-07-01-2013-Middle-class-boom:-The-image-of-new-Bangladesh-372-2-17-1-1.html (accessed 15 August 2013).
57. Khan, M.H.-U.-Z. and Ali, M.M. (2010), "An empirical investigation and users' perceptions on intellectual capital reporting in banks - evidence from Bangladesh", Journal of Human Resource Costing & Accounting, Vol. 14 No. 1, pp. 48-69.
58. Khan, M.H.-U.-Z. and Khan, M.R. (2010), "Human capital disclosure practices of top Bangladeshi companies", Journal of Human Resource Costing & Accounting, Vol. 14 No. 4, pp. 329-349.
59. Libra Infusions Limited (2006), Annual Report 2005-2006: An Obsession With Quality, Libra Infusions Limited, Dhaka.
60. Mangena, M., Pike, R. and Li, J. (2010), Intellectual Capital Disclosure Practices and Effects on the Cost of Equity Capital: UK Evidence, The Institute of Chartered Accountants of Scotland, Edinburgh.
61. Masud, M. (2013), "Bangladesh pharmaceutical sector: An overview", available at: Www.pharmabiz.com/ArticleDetails.aspx?aid=77989&sid=21 (accessed 3 January 2014).
62. Mehralian, G., Rajabzadeh, A., Sadeh, M.R. and Rasekh, H.R. (2012), "Intellectual capital and corporate performance in Iranian pharmaceutical industry", Journal of Intellectual Capital, Vol. 13 No. 1, pp. 138-158.
63. Merkl-Davies, D.M. and Brennan, N.M. (2011), "A conceptual framework of impression management: new insights from psychology, sociology and critical perspectives", Accounting and Business Research, Vol. 41 No. 5, pp. 415-437.
64. Nurunnabi, M., Hossain, M. and Hossain, M. (2011), "Intellectual capital reporting in a South Asian country: Evidence from Bangladesh", Journal of Human Resource Costing & Accounting, Vol. 15 No. 3, pp. 196-233.
65. Oliveira, L., Rodrigues, L.L. and Craig, R. (2006), "Firm-specific determinants of intangibles reporting: Evidence from the Portuguese stock market", Journal of Human Resource Costing and Accounting, Vol. 10 No. 1, pp. 11-33.
66. O'Neill, J., Wilson, D., Purushothaman, R. and Stupnytska, A. (2005), Global Economics Paper No: 134 - How Solid are the BRICs, Goldman Sachs & Co, New York, NY.
67. Ousama, A.A., Fatima, A.-H. and Hafiz-Majdi, A.R. (2011), "Effects of intellectual capital information disclosed in annual reports on market capitalization: Evidence from Bursa Malaysia", Journal of Human Resource Costing & Accounting, Vol. 15 No. 2, pp. 85-101.
68. Ousama, A.A., Fatima, A.-H. and Hafiz-Majdi, A.R. (2012), "Determinants of intellectual capital reporting: Evidence from annual reports of Malaysian listed companies", Journal of Accounting in Emerging Economies, Vol. 2 No. 2, pp. 119-139.
69. Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R. and Schacht, A.L. (2010), "How to improve R&D productivity: The pharmaceutical industry's grand challenge", Nat Rev Drug Discov, Vol. 9 No. 3, pp. 203-214.
70. Penrose, J.M. (2008), "Annual report graphic use: A review of the literature", Journal of Business Communication, Vol. 45 No. 2, pp. 158-180.
71. Qaiser, B. (2010), "Pharma sector forcing off the pace", available at: http://bangladesheconomy.wordpress.com/category/pharmaceutical-industryhealthcare/page/2/(accessed 15 August 2013).
72. Rahman, S. and Azim, M. (2011), "Corporate social reporting by pharmaceutical companies in a LDC: A hard pill to swallow", available at: http://dx.doi.org/10.2139/ssrn.1950032 (accessed 14 January 2014).
73. Rashid, M. (2009), "Toward a middle income country", available at: Www.thedailystar.net/newDesign/news-details.php?nid=77161 (accessed 15 February 2013).
74. Reckitt Benckiser (Bangladesh) Limited (2006), Annual Report 2006 - A Passion to Perform, Reckitt Benckiser (Bangladesh) Limited, Chittagong.
75. Ritter, A. and Wells, P. (2006), "Identifiable intangible assets disclosures, stock prices and future earnings", Accounting and Finance, Vol. 46 No. 4, pp. 843-863.
76. Saad, K.S. (2012), An Overview of the Pharmaceutical Sector in Bangladesh, BRAC EPL Stock Brokerage Limited, Dhaka.
77. Sciulli, N., Wise, V., Demediuk, P. and Sims, R. (2002), "Intellectual capital reporting: An examination of local government in Victoria", Accounting, Accountability & Performance, Vol. 8 No. 8, pp. 43-60.
78. Shafiuzzaman, S.M. (2004), "Bangladesh pharmaceutical sector: A vision of success", available at: Www.bapibd.com/articles-president.pdf (accessed 15 August 2013).
79. Sharabati, A.-A.A., Jawad, S.N. and Bontis, N. (2010), "Intellectual capital and business performance in the pharmaceutical sector of Jordan", Management Decision, Vol. 48 No. 1, pp. 105-131.
80. Singh, S. and Kansal, M. (2011), "Voluntary disclosures of intellectual capital: An empirical analysis", Journal of Intellectual Capital, Vol. 12 No. 2, pp. 301-318.
81. Society for Knowledge Economics (2005), Australian Guiding Principles on Extended Performance Management: A Guide to Better Managing, Measuring and Reporting Knowledge Intensive Organisational Resources, SKE, Crows Nest.
82. Steenkamp, N. (2007), "Intellectual capital reporting in New Zealand: Refining content analysis as a research method", unpublished PhD thesis, Auckland University of Technology, Auckland.
83. Sujan, A. and Abeysekera, I. (2007), "Intellectual capital reporting practices of the top Australian firms", Australian Accounting Review, Vol. 17 No. 2, pp. 71-83.
84. Square Pharmaceuticals Limited (2006), Annual Report 2005-2006, Square Pharmaceuticals Limited, Dhaka.
85. Van der Meer-Kooistra, J. and Zijlstra, S.M. (2001), "Reporting on intellectual capital", Accounting, Auditing and Accountability Journal, Vol. 14 No. 4, pp. 456-476.
86. Verrecchia, R.E. (1983), "Discretionary disclosure", Journal of Accounting and Economics, Vol. 5 No. 2, pp. 179-194.
87. Wagiciengo, M.M. and Belal, A.R. (2012), "Intellectual capital disclosures by South African companies: A longitudinal investigation", Advances in Accounting, incorporating Advances in International Accounting, Vol. 28 No. 1, pp. 111-119.
88. White, G., Lee, A., Yuningsih, Y., Nielsen, C. and Bukh, P.N. (2010), "The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies", Journal of Intellectual Capital, Vol. 11 No. 4, pp. 519-536.
89. Wyatt, A. and Frick, H. (2010), "Accounting for investments in human capital: A review", Australian Accounting Review, Vol. 20 No. 3, pp. 199-220.
90. Yau, F.S., Chun, L.S. and Balaraman, R. (2009), "Intellectual capital reporting and corporate characteristics of public-listed companies in Malaysia", Journal of Financial Reporting and Accounting, Vol. 7 No. 1, pp. 17-35. 126.
91. Yi, A. and Davey, H. (2010), "Intellectual capital disclosure in Chinese (mainland) companies", Journal of Intellectual Capital, Vol. 11 No. 3, pp. 326-347.
92. Yi, A., Davey, H. and Eggleton, I.R.C. (2011), "The effects of industry type, company size and performance on Chinese companies' IC disclosure: A research note", Australasian Accounting Business and Finance Journal, Vol. 5 No. 3, pp. 107-116.